Emily Perdoncin, MD
Interventional Cardiology · Portsmouth, VANPI 1740574557
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (50.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Medtronic at 56.4% of the total. Reporting peaked in 2020 at $10,758 and has fallen 57.4% since, to $4,583 in 2025.
Across 127 payments — averaging $164.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Abbott$5K
- Edwards Lifesciences$2K
- Abiomed$289
- Corindus Inc.$242
- Boston Scientific$174
- plus $1K from 21 others
What the payments were for
- Grants$10,50050%
- Travel & lodging$4,74223%
- Food & beverage$5,60527%
- Education$750%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 13 | $11,803 |
| Abbott | 31 | $4,852 |
| Edwards Lifesciences | 13 | $2,188 |
| Abiomed | 2 | $289 |
| Corindus Inc. | 2 | $242 |
| Boston Scientific | 2 | $174 |
| AstraZeneca | 7 | $159 |
| Cardiovascular Systems Inc. | 3 | $156 |
| Amgen | 9 | $135 |
| Biotronik Inc. | 1 | $122 |
| Novartis | 8 | $118 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $115 |
| W. L. Gore & Associates, Inc. | 1 | $73 |
| Chiesi USA, Inc. | 3 | $57 |
| Pfizer | 4 | $48 |
| Amarin Pharma, Inc. | 3 | $47 |
| Sanofi-aventis U.S. LLC | 3 | $46 |
| E.r. Squibb & Sons, L.L.C. | 3 | $40 |
| Portola Pharmaceuticals, LLC | 2 | $39 |
| Philips North America LLC | 2 | $36 |
| Irhythm Technologies, Inc. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Boehringer Ingelheim | 2 | $29 |
| Johnson & Johnson | 2 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Cardiva Medical, Inc. | 1 | $24 |
| Terumo Medical Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$1,960
- TRICLIP$1,233
- NAVITOR$1,067
- EVOQUE$959
- COREVALVE EVOLUT R$835
- Impella$289
- CorPath GRX$229
- ONYX FRONTIER$184
- GENERAL - THERAPIES$151
- Coronary Orbital Atherectomy System$123
- CoreValve Evolut$121
How this compares
$20,922 in reported general payments places this provider in the 85th percentile of 176 interventional cardiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Portsmouth
- Deepak TalrejaVirginia Beach$1.5M
- Rajiv TayalFredericksburg$984K
- Gansevoort DunningtonRichmond$440K
- Matthew SummersNorfolk$308K
- Noah JonesFalls Church$238K
- Michael GenVirginia Beach$207K
- Jeremy BockLeesburg$202K
- Wayne BatchelorFalls Church$196K
- Matthew SherwoodFalls Church$193K
- Jason FoerstRoanoke$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.